Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-094580
Filing Date
2025-07-08
Accepted
2025-07-08 16:05:06
Documents
1
Period of Report
2025-06-16

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2854
  Complete submission text file 0000950170-25-094580.txt   4584
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Issuer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O BROOKLYN IMMUNOTHERAPEUTICS, INC. 140 58TH STREET, BUILDING A, SUITE 2100 BROOKLYN NY 11220
Business Address
Sidhu Roger (Reporting) CIK: 0001884115 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35558 | Film No.: 251111087